Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

IMPORTANCE: As many as 55% of patients with non–small cell lung cancer (NSCLC) present with stage IV disease at diagnosis. Although systemic therapy is the cornerstone for treatment of these patients, growing evidence suggests that local treatment of the primary tumor site may improve survival. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707019/
https://www.ncbi.nlm.nih.gov/pubmed/31433481
http://dx.doi.org/10.1001/jamanetworkopen.2019.9702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707019/
https://www.ncbi.nlm.nih.gov/pubmed/31433481
http://dx.doi.org/10.1001/jamanetworkopen.2019.9702

Ejemplares similares